We did not observe an increased risk of all-cause mortality (adjusted HR 1.00; 95% CI 0.99–1.01), CV mortality (adjusted HR 1.00; 95% CI 0.98–1.01) and cancer related mortality (adjusted HR 0.99; 95% CI 0.98–1.01) per unit increase in serum IL8. The gene discussed is CXCL8; the disease is cancer.